GlassScriptPhysician profile
Patrick Matthew Kosciuk
NPI 1659791473
$6,840.05
in general payments reported to CMS, 2019-2025
9 companies · $341 in 2025
The $341 reported for 2025 was less than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $20.07 · 2021: $1,302 · 2022: $1,264 · 2023: $3,073 · 2024: $840 · 2025: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,715 · Food and Beverage: $1,539.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,715.26 |
| Food and Beverage | $1,538.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,653.12 | 2022-2025 | Da Vinci Surgical System |
| Pulmonx Corporation | $1,744.61 | 2021-2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Ethicon INC. | $652.50 | 2021-2023 | Monarch Platform |
| Pinnacle Biologics, INC | $554.16 | 2020-2021 | |
| Olympus America INC. | $335.93 | 2022-2025 | Single-Use Flexible Video Bronchoscope |
| Siemens Medical Solutions USA, INC. | $323.61 | 2024 | Cios Spin |
| Steris Corporation | $232.70 | 2022 | |
| Boston Scientific Corporation | $232.16 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $111.26 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Kosciuk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.